ublituximab

E2190200 UNEXPLORED

Ublituximab is a glycoengineered anti-CD20 monoclonal antibody used to deplete B cells in conditions such as multiple sclerosis and certain B-cell malignancies.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
ublituximab canonical	1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

MS4A1 → targetOfDrug → ublituximab ⓘ

subject linked to: MS4A1 gene